Famotidine and Cobamamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Famotidine (famotidine) and Cobamamide (dibencozide). Common drug interactions include back pain among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Famotidine and Cobamamide. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,423 Famotidine users. Check the latest studies of Famotidine.

What is Cobamamide?

Cobamamide has active ingredients of dibencozide. eHealthMe is studying from 1,046 Cobamamide users. Check the latest studies of Cobamamide.



On Aug, 01, 2026

44 people who take Famotidine and Cobamamide together, and have interactions are studied.

Famotidine and Cobamamide drug interactions.

What are the common drug interactions of Famotidine and Cobamamide, by gender? *:

female:

  1. Back pain
  2. Diarrhoea
  3. Drug hypersensitivity
  4. Hereditary angioedema (recurrent episodes of severe swelling)
  5. Infection
  6. Injection site haemorrhage (bleeding from injection site)
  7. Injection site pain
  8. Injection site rash
  9. Nerve injury
  10. Sinus disorder (disease of sinus)

male:

  1. Cellulitis (infection under the skin)
  2. Mesenteric artery thrombosis (blood clot in mesenteric artery)
  3. Breast swelling
  4. Burning sensation
  5. Dizziness exertional
  6. Fatigue (feeling of tiredness)
  7. Fluid imbalance (imbalance of fluid in body in intake and fluid lost)
  8. Galactostasis (accumulate too much milk during late pregnancy and lactation)
  9. Joint swelling
  10. Lens discolouration

What are the common drug interactions of Famotidine and Cobamamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Burning sensation
  4. Joint swelling
  5. Limb discomfort (discomfort in leg)
  6. Neuropathy peripheral (surface nerve damage)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

30-39:

n/a

40-49:

  1. Platelet count decreased
  2. Cystic fibrosis (disease of the secretary glands)
  3. Pneumonia

50-59:

  1. Mesenteric artery thrombosis (blood clot in mesenteric artery)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Toothache (tooth pain)
  4. Visual impairment

60+:

  1. Cellulitis (infection under the skin)
  2. Back pain
  3. Injection site pain
  4. Injection site rash
  5. Nerve injury
  6. Pneumonia
  7. Sinus disorder (disease of sinus)
  8. Syncope (loss of consciousness with an inability to maintain postural tone)
  9. Decreased appetite
  10. Incisional hernia (hernia caused by an incompletely-healed surgical wound)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 15 people, 34.09%
  2. Cancer Pain: 12 people, 27.27%
  3. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 15.91%
  4. Oedema Peripheral (superficial swelling): 6 people, 13.64%
  5. Rashes (redness): 5 people, 11.36%
  6. High Blood Pressure: 5 people, 11.36%
  7. Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 9.09%
  8. Acidosis (build-up of carbon dioxide in the blood): 4 people, 9.09%
  9. Metastatic Neoplasm (spreadable cancer tumour): 3 people, 6.82%
  10. Itching: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and Cobamamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Famotidine and Cobamamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Famotidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cobamamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Famotidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cobamamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and dibencozide (the active ingredients of Famotidine and Cobamamide, respectively), and Famotidine and Cobamamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: